<DOC>
	<DOCNO>NCT01203228</DOCNO>
	<brief_summary>In trial dose reduce conditioning compare standard conditioning follow allogeneic stem cell transplantation relate unrelated donor patient MDS secondary AML . Conditioning high dose chemotherapy treatment give day stem cell transplant . The hypothesis dose reduce condition reduce non-relapse mortality 40 % 20 % one year allogeneic stem cell transplantation .</brief_summary>
	<brief_title>Dose-reduced Versus Standard Conditioning MDS/sAML</brief_title>
	<detailed_description />
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<criteria>Disease : Cytologically proven primary therapyrelated myelodysplastic syndrome ( MDS ) , either refractory anaemia ( RA ) accord FAB RA without dysplasia accord WHO , refractory anaemia ringsideroblasts ( RARS ) accord FAB RARS without dysplasia accord WHO , refractory anaemia excess blast ( RAEB ) accord FAB RAEB I RAEB II accord WHO , refractory anaemia excess blast transformation ( RAEB T ) accord FAB , CMML ( dysplastic type ) accord WHO , secondary acute myeloid leukaemia ( sAML ) . Blast count &lt; 20 percent bone marrow without chemotherapy time transplantation . Patient eligible standard dosereduced condition per local guideline . Patient age 18 60 year donor HLAmatched unrelated donor ( HLAA , HLAB , HLADRB1 HLADQB1 ) ( one mismatch allow ) : Patient age 18 65 year donor HLAmatched related donor ( ( HLAA , HLAB , HLADRB1 HLADQB1 ) ( one antiÂ¬genmismatch allow ) : No major organ dysfunction . Written informed consent patient . Blasts &gt; 20 % bone marrow time transplantation No write informed consent . Central nervous involvement . Severe irreversible renal , hepatic , pulmonary cardiac disease , Total bilirubin , SGPT SGOT &gt; 2 time upper normal level . Left ventricular ejection fraction &lt; 30 % . Creatinine clearance &lt; 30 ml/min . DLCO &lt; 35 % and/or receive supplementary continuous oxygen . Positive serology HIV . Pregnant lactate woman . Patients lifeexpectancy less six month another debilitate disease . Serious psychiatric psychological disorder . Invasive fungal infection time registration .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Reduced Intensity conditioning</keyword>
	<keyword>Myeloablative conditionig</keyword>
	<keyword>Allogeneic stem cell transplantation</keyword>
	<keyword>MUD</keyword>
</DOC>